Logo image of EHLD

EURO-HOLDINGS LTD (EHLD) Stock Fundamental Analysis

NASDAQ:EHLD - Nasdaq - MHY234DY1099 - Common Stock - Currency: USD

6.18  -0.01 (-0.16%)

Fundamental Rating

2

Overall EHLD gets a fundamental rating of 2 out of 10. We evaluated EHLD against 0 industry peers in the Unkown industry. EHLD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EHLD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EHLD had positive earnings in the past year.
In the past year EHLD had a positive cash flow from operations.
EHLD Yearly Net Income VS EBIT VS OCF VS FCFEHLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M

1.2 Ratios

The last Return On Invested Capital (48.49%) for EHLD is well below the 3 year average (92.54%), which needs to be investigated, but indicates that EHLD had better years and this may not be a problem.
Industry RankSector Rank
ROA 43.79%
ROE 60.42%
ROIC 48.49%
ROA(3y)92.57%
ROA(5y)N/A
ROE(3y)139.88%
ROE(5y)N/A
ROIC(3y)92.54%
ROIC(5y)N/A
EHLD Yearly ROA, ROE, ROICEHLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 50 100 150 200

1.3 Margins

Industry RankSector Rank
OM 23.94%
PM (TTM) 23.56%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EHLD Yearly Profit, Operating, Gross MarginsEHLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40 50

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EHLD is creating value.
Compared to 1 year ago, EHLD has about the same amount of shares outstanding.
EHLD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EHLD Yearly Shares OutstandingEHLD Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 500K 1M 1.5M 2M 2.5M
EHLD Yearly Total Debt VS Total AssetsEHLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

EHLD has an Altman-Z score of 8.75. This indicates that EHLD is financially healthy and has little risk of bankruptcy at the moment.
EHLD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.75
ROIC/WACC5.41
WACC8.97%
EHLD Yearly LT Debt VS Equity VS FCFEHLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.00 indicates that EHLD should not have too much problems paying its short term obligations.
A Quick Ratio of 0.73 indicates that EHLD may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.73
EHLD Yearly Current Assets VS Current LiabilitesEHLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

EHLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.09%.
Looking at the last year, EHLD shows a decrease in Revenue. The Revenue has decreased by -3.01% in the last year.
EPS 1Y (TTM)-51.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-51.09%
Revenue 1Y (TTM)-3.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EHLD Yearly Revenue VS EstimatesEHLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.61, the valuation of EHLD can be described as very cheap.
EHLD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
Industry RankSector Rank
PE 4.61
Fwd PE N/A
EHLD Price Earnings VS Forward Price EarningsEHLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 3.67
EV/EBITDA 4.5
EHLD Per share dataEHLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EHLD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EURO-HOLDINGS LTD

NASDAQ:EHLD (6/5/2025, 8:00:01 PM)

6.18

-0.01 (-0.16%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.43M
AnalystsN/A
Price TargetN/A
Short Float %0.93%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.61
Fwd PE N/A
P/S 1.09
P/FCF 3.67
P/OCF 3.51
P/B 2.79
P/tB 2.79
EV/EBITDA 4.5
EPS(TTM)1.34
EY21.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.68
FCFY27.26%
OCF(TTM)1.76
OCFY28.46%
SpS5.67
BVpS2.21
TBVpS2.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 43.79%
ROE 60.42%
ROCE 61.38%
ROIC 48.49%
ROICexc 48.49%
ROICexgc 48.49%
OM 23.94%
PM (TTM) 23.56%
GM N/A
FCFM 29.69%
ROA(3y)92.57%
ROA(5y)N/A
ROE(3y)139.88%
ROE(5y)N/A
ROIC(3y)92.54%
ROIC(5y)N/A
ROICexc(3y)100.05%
ROICexc(5y)N/A
ROICexgc(3y)100.05%
ROICexgc(5y)N/A
ROCE(3y)117.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 525%
Cap/Sales 1.31%
Interest Coverage 250
Cash Conversion 128.17%
Profit Quality 126%
Current Ratio 1
Quick Ratio 0.73
Altman-Z 8.75
F-Score4
WACC8.97%
ROIC/WACC5.41
Cap/Depr(3y)192.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.84%
Cap/Sales(5y)N/A
Profit Quality(3y)112.66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-51.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.67%
OCF growth 3YN/A
OCF growth 5YN/A